Interactions between prostaglandin E2, liver receptor homologue-1, and aromatase in breast cancer

Cancer Research

Volumn 65, Issue 2, 2005, Pages 657-663

  Zhou, Jiong ^a   Suzuki, Takashi ^b   Kovacic, Agnes ^a   Saito, Ryoko ^b   Miki, Yasuhiro ^b   Ishida, Takanori ^b   Moriya, Takuya ^b   Simpson, Evan R ^a   Sasano, Hironobu ^b   Clyne, Colin D ^a,c  

^a MONASH UNIVERSITY   (Australia)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CELL RECEPTOR; ESTROGEN; MESSENGER RNA; PROSTAGLANDIN E2;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; MACROPHAGE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

ADIPOSE TISSUE; ADULT; AGED; AROMATASE; BREAST NEOPLASMS; DINOPROSTONE; DNA-BINDING PROTEINS; ENZYME INDUCTION; FEMALE; HUMANS; MIDDLE AGED; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; STROMAL CELLS; TRANSCRIPTION FACTORS;

EID: 19944430970     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Ristimaki A, Sivula A, Lundin J, et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 2002;62:632-5.
2. Liu CH, Chang SH, Narko K, et al. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 2001;276:18563-9.
3. Alshafie GA, Abou-Issa HM, Seibert K, Harris RE. Chemotherapeutic evaluation of celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model. Oncol Rep 2000;7:1377-81.
4. Harris RE, Alshafie GA, Abou-Issa H, Seibert K. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res 2000;60:2101-3.
5. Howe LR, Subbaramaiah K, Patel J, et al. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Cancer Res 2002;62:5405-7.
6. Cotterchio M, Kreiger N, Sloan M, Steingart A. Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:1213-7.
7. Harris HE, Chlebowski RT, Jackson RD, et al. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res 2003;63:6096-101.
8. Simpson ER, Clyne C, Rubin G, et al. Aromatase - a brief overview. Annu Rev Physiol 2002;64:93-127.
9. Thorsen T, Tangen M, Stoa KF. Concentration of endogenous oestradiol as related to oestradiol receptor sites in breast tumor cytosol. Eur J Cancer Clin Oncol 1982;18:333-7.
10. van Landeghem AA, Poortman J, Nabuurs M, Thijssen JH. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res 1985;45:2900-6.
11. Bulun SE, Price TM, Aitken J, Mahendroo MS, Simpson ER. A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metab 1993;77:1622-8.
12. Harada N. Aberrant expression of aromatase in breast cancer tissues. J Steroid Biochem Mol Biol 1997;61:175-84.
13. Agarwal VR, Bulun SE, Leitch M, Rohrich R, Simpson ER Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J Clin Endocrinol Metab 1996;81:3843-9.
14. Harada N, Utsumi T, Takagi Y. Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proc Natl Acad Sci U S A 1993;90:11312-6.
15. Zhou D, Zhou C, Chen S. Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells. J Steroid Biochem Mol Biol 1997;61:273-80.
16. 2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 1996;137:5739-42.
17. 2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes. J Clin Endocrinol Metab 2003;88:2810-6.
18. Sofi M, Young MJ, Papamakarios T, Simpson ER, Clyne CD. Role of CRE-binding protein (CREB) in aromatase expression in breast adipose. Breast Cancer Res Treat 2003;79:399-407.
19. Michael MD, Kilgore MW, Morohashi K, Simpson ER Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary. J Biol Chem 1995;270:13561-6.
20. Carlone DL, Richards JS. Evidence that functional interactions of CREB and SF-1 mediate hormone regulated expression of the aromatase gene in granulosa cells and constitutive expression in R2C cells. J Steroid Biochem Mol Biol 1997;61:223-31.
21. Zeitoun K, Takayama K, Michael MD, Bulun SE. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis -acting element. Mol Endocrinol 1999;13:239-53.
22. Yang C, Zhou D, Chen S. Modulation of aromatase expression in the breast tissue by ERRα-1 orphan receptor. Cancer Res 1998;58:5695-700.
23. Yang C, Yu B, Zhou D, Chen S. Regulation of aromatase promoter activity in human breast tissue by nuclear receptors. Oncogene 2002;21:2854-63.
24. Catalano S, Pezzi V, Chimento A, et al. Triiodothyronine (T3) decreases the activity of the proximal promoter (PlI) of the aromatase gene in the mouse Sertoli cell line, TM4. Mol Endocrinol 2003;17:923-34.
25. Clyne CD, Speed CJ, Zhou J, Simpson ER. Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes. J Biol Chem 2002;277:20591-7.
26. Ried T, Just KE, Holtgreve-Grez H, et al. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res 1995;55:5415-23.
27. Forozan F, Mahlamaki EH, Monni O, et al. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res 2000;60:4519-25.
28. Hu J, Wills M, Baker BA, Perlman EJ. Comparative genomic hybridization analysis of hepatoblastomas. Genes Chromosomes Cancer 2000;27:196-201.
29. Leung TH, Wong N, Lai PB, et al. Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma. Mod Pathol 2002;15:1213-20.
30. Wang G, Zhao Y, Liu X, et al. Allelic loss and gain, but not genomic instability, as the major somatic mutation in primary hepatocellular carcinoma. Genes Chromosomes Cancer 2001;31:221-7.
31. Sonoda G, Palazzo J, du MS, et al. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer 1997;20:320-8.
32. Knuutila S, Bjorkqvist AM, Autio K, et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 1998;152:1107-23.
33. Ackerman GE, Smith ME, Mendelson CR, MacDonald PC, Simpson ER. Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J Clin Endocrinol Metab 1981;53:412-7.
34. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science 1996;274:998-1001.
35. Niino YS, Irie T, Takaishi M, et al. PKCθ II, a new isoform of protein kinase C specifically expressed in the seminiferous tubules of mouse testis. J Biol Chem 2001;276:36711-7.
36. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
37. Bulun SE, Rosenthal IM, Brodie AM, et al. Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads. J Clin Endocrinol Metab 1994;78:1616-21.
38. Sasano H, Nagura H, Harada N, Goukon Y, Kimura M. Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol 1994;25:530-5.
39. Santen RJ, Martel J, Hoagland M, et al. Stromal spindle cells contain aromatase in human breast tumors. J Clin Endocrinol Metab 1994;79:627-32.
40. Santner SJ, Pauley RJ, Tait L, Kaseta J, Santen RJ. Aromatase activity and expression in breast cancer and benign breast tissue stromal cells. J Clin Endocrinol Metab 1997;82:200-8.
41. Zhou J, Curates B, Yang S, Sebastian S, Bulun SE. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein β. Cancer Res 2001;61:2328-34.
42. Suzuki T, Miki Y, Moriya T, et al. Estrogen-related receptor α in human breast carcinoma as a potent prognostic factor. Cancer Res 2004;64:4670-6.
43. Galarneau L, Pare JF, Allard D, et al. The α1-fetoprotein locus is activated by a nuclear receptor of the Drosophila FTZ-F1 family. Mol Cell Biol 1996;16:3853-65.
44. Li M, Xie YH, Kong YY, Wu X, Zhu L, Wang Y. Cloning and characterization of a novel human hepatocyte transcription factor, hB1F, which binds and activates enhancer II of hepatitis B virus. J Biol Chem 1998;273:29022-31.
45. Nitta M, Ku S, Brown C, Okamoto AY, Shan B. CPF: an orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7α-hydroxylase gene. Proc Natl Acad Sci U S A 1999;96:6660-5.
46. Rausa FM, Galarneau L, Belanger L, Costa RH. The nuclear receptor fetoprotein transcription factor is coexpressed with its target gene HNF-3β in the developing murine liver, intestine and pancreas. Mech Dev 1999;89:185-8.
47. Mizejewski GJ. Biological role of α-fetoprotein in cancer: prospects for anticancer therapy. Expert Rev Anticancer Ther 2002;2:709-35.
48. Nakao K, Ochi H, Kawashima M, Tomino S, Sugano H, Matsumoto K. Estrogen receptor and α-fetoprotein in human breast cancer: brief communication. J Natl Cancer Inst 1978;60:289-90.
49. Sarcione EJ, Hart D. Biosynthesis of α fetoprotein by MCF-7 human breast cancer cells. Int J Cancer 1985;35:315-8.
50. Leal JA, Gangrade BK, Kiser JL, May JV, Keel BA. Human mammary tumor cell proliferation: primary role of platelet-derived growth factor and possible synergism with human α-fetoprotein. Steroids 1991;56:247-51.